Alessandra Fanciulli (Austria)

Medical University of Innsbruck Department of Neurology
I am the deputy Director of the Innsbruck Dysautonomia Center and my research focuses on syncope and autonomic failure in multiple system atrophy and other neurodegenerative disorders.

Author Of 2 Presentations

ORTHOSTATIC HYPOTENSION AND SUPINE HYPERTENSION - DIAGNOSIS & TREATMENT

Session Type
Teaching Course
Date
04.10.2021, Monday
Session Time
17:25 - 18:30
Room
Teaching Course A
Lecture Time
17:40 - 17:55
Presenter
  • Alessandra Fanciulli (Austria)
Scientific Session: MT (Main Topics)

THERAPEUTIC OPTIONS IN AUTONOMIC DISORDERS

Session Type
Scientific Session: MT (Main Topics)
Date
03.10.2021, Sunday
Session Time
17:10 - 18:40
Room
Main Topic C
Lecture Time
17:56 - 18:19
Presenter
  • Alessandra Fanciulli (Austria)

Abstract

Abstract Body

An individualized management of autonomic disorders requires a careful preliminary assessment not only of the type and severity degree of autonomic failure, but also of the patient’s preferences, therapeutic expectations and other disease-related aspects, such as the presence of motor or cognitive impairment. Non-pharmacological and pharmacological options are to be introduced in a stepwise fashion based on the symptomatic burden in single patients. Any interventional measure also requires a close follow-up to monitor for the therapeutic outcome, compliance and eventual side effects.

Hide

Presenter of 2 Presentations

ORTHOSTATIC HYPOTENSION AND SUPINE HYPERTENSION - DIAGNOSIS & TREATMENT

Session Type
Teaching Course
Date
04.10.2021, Monday
Session Time
17:25 - 18:30
Room
Teaching Course A
Lecture Time
17:40 - 17:55
Presenter
  • Alessandra Fanciulli (Austria)
Scientific Session: MT (Main Topics)

THERAPEUTIC OPTIONS IN AUTONOMIC DISORDERS

Session Type
Scientific Session: MT (Main Topics)
Date
03.10.2021, Sunday
Session Time
17:10 - 18:40
Room
Main Topic C
Lecture Time
17:56 - 18:19
Presenter
  • Alessandra Fanciulli (Austria)

Abstract

Abstract Body

An individualized management of autonomic disorders requires a careful preliminary assessment not only of the type and severity degree of autonomic failure, but also of the patient’s preferences, therapeutic expectations and other disease-related aspects, such as the presence of motor or cognitive impairment. Non-pharmacological and pharmacological options are to be introduced in a stepwise fashion based on the symptomatic burden in single patients. Any interventional measure also requires a close follow-up to monitor for the therapeutic outcome, compliance and eventual side effects.

Hide